Johns Hopkins at the ACR Annual Meeting
Johns Hopkins faculty will participate in ACR Convergence 2026 from November 6-11 in Orlando, FL. Choose a date below to see the schedule of presentations and additional details. All times listed are in Eastern Standard Time (EST)
Meet Our Professors
Stop by our booth daily at 4815-NP to meet with our faculty!
| Date | Faculty Name | Discussion Time | Specialty |
|---|---|---|---|
| 11/08 | Lisa Christopher-Stine, MD, MPH | 11:30AM-12:00PM | Myositis |
| Laura Cappelli, MD, MHS |
12:00PM-12:30PM | Arthritis/Immune related Adverse Effects from Cancer Immunotherapy |
|
| Alan Baer, MD |
12:30PM-1:00PM |
Sjogren's Disease |
|
| 11/09 |
Ana-Maria Orbai, MD, MHS |
11:30AM-12:00PM |
Arthritis |
| Myma Albayda, MD |
12:00PM-12:30PM |
Myositis/Gout/Ultrasound/Fellowship |
|
| Laura Hummers, MD, ScM |
12:30PM-1:00PM |
Scleroderma |
|
| 11/10 |
Julie Paik, MD, MHS |
11:30AM-12:00PM |
Myositis/Scleroderma |
| Brendan Antiochos, MD |
12:00PM-12:30PM |
Vasculitis |
View schedule by date:
Nov. 6 | Nov. 7 | Nov. 8 | Nov. 9 | Nov. 10 | Nov. 11
| Faculty Name | Presentation Time | Presentation Type | Title | Location |
|---|---|---|---|---|
| Jemima Albayda, MD | 1:00PM-1:30PM | Hands-On Training | Intermediate-Advanced Rheumatologic Ultrasound Course I: Sonographic Dissection of the Ankle and the Subtalar Joint | W110A |
| Faculty name | Time | Presentation Type | Title | Location |
|---|---|---|---|---|
| Laura Cappelli, MD, MHS | 7:50AM-8:25AM | Scientific Session | Check Your Knowledge Management of Rheumatic Diseases Induced by Cancer Immunotherapy | Hall B, WB3, & WB4 |
| Faculty name | Time | Presentation Type | Title | Location |
|---|---|---|---|---|
| Andrew Mammen, MD, PhD | 9:00AM-9:30AM | Scientific Session | Decoding Myositis: From Mechanism to Medicine: Autoantibodies and Immune Phenotyping in Inflammatory Myositis | W206 |
| Susan Bartlett, PhD | 10:30AM-12:30AM | Poster Session A | 0500: Poorer Mental Health at Initiation of First Advanced Therapy in Early RA is Associated with Higher Medication Concerns and Earlier Treatment Discontinuation: Findings from the Canadian Early Arthritis Cohort (CATCH) |
Poster Hall |
| Susan Bartlett, PhD | 10:30AM-12:30AM | Poster Session A | 0507: Same Treatment, Different Outcomes: At Initiation of First Advanced Therapy in Early RA, Mental Health Predicts Worse Treatment Response at 6-12 Months | Poster Hall |
| Ana-Maria Orbai, MD, MHS | 10:30AM-12:30AM | Poster Session A |
0394: Patient-Reported Treatment Success and Clinical DAPSA Define Prognostic Disease States in Psoriatic Arthritis | Poster Hall |
| Michelle Petri, MD, MPH | 10:30AM-12:30AM |
Poster Session A |
0275: Pharmacodynamics of Nipocalimab, a Fully Human FcRn-Blocking Monoclonal Antibody, in Adults With Systemic Lupus Erythematosus: Results From a Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study (JASMINE-SLE) | Poster Hall |
| Marwin Groener, MD (Fellow) | 10:30AM-12:30AM |
Poster Session A |
0646: Anti-HMGCR Immune-mediated Necrotizing Myopathy Shows Robust Treatment Response With Early Rituximab Initiation | Poster Hall |
| Ning Meng, MS | 10:30AM-12:30AM |
Poster Session A |
0607: Treat‑to‑Target Achieved, Fatigue Persists: Cross‑Sectional Insights into Mediators of Residual Fatigue |
Poster Hall |
| Brock Moritz (Graduate Student) | 10:30AM-12:30AM |
Poster Session A |
0144: Autoantigen-Drug Conjugates (AADCs) Selectively Target Autoreactive B Cells in Autoimmune Diseases | Poster Hall |
| Sarah Smith, MD (Fellow) | 10:30AM-12:30AM |
Poster Session A |
0245: Skin Trajectory and Clinical Features Associated with Five-Year Survival in Diffuse Cutaneous Systemic Sclerosis | Poster Hall |
| Laura Hummers, MD, ScM | 11:30AM-12:30PM | Meet the Professor | Systemic Sclerosis | W103A |
| Faith Obilo (RPC) | 1:45PM-2:00PM | Abstract Session | 0923: The Disparate Effect of Statins on eGFR in Systemic Lupus Erythematosus | W415BC |
| Ji Soo Kim, PhD | 3:30PM-3:45PM | Abstract Session | 0952: Identification of risk factors for renal crisis and chronic kidney dysfunction in patients with systemic sclerosis | W415BC |
| Colin Gliech (Postdoc Fellow) | 3:30PM-3:45PM | Abstract Session | 0928: CATCR-T Cells for the Antigen-Specific Treatment of ANCA-Associated Vasculitis | W110B |
| Faculty name | Time | Presentation Type | Title | Location |
|---|---|---|---|---|
| Thomas Grader-Beck, MD | 8:00AM-8:15AM | Abstract Session | 1856: Salivary Gland Ultrasonography Severity Reflects Progressive Exocrine Dysfunction in Sjögren's Disease | W415BC |
| Clifton O. Bingham, III, MD | 10:00AM-10:30AM | Scientific Session | From Data to Impact: PROMIS in Rheumatology Research |
W311GH |
| Michelle Petri, MD, MPH | 10:00AM-11:30AM | Scientific Session | Early Systemic Lupus Erythematosus: Recognizing the First Signals and Predicting Disease Trajectory |
W415A |
| Lisa Christopher-Stine, MD, MPH |
10:30AM-12:30AM | Poster Session B | 1587: Brepocitinib Improves Patient-Reported Physical Disability, Pain, and Fatigue in Dermatomyositis Patients at One Year | Poster Hall |
| Andrea Fava, MD | 10:30AM-12:30AM |
Poster Session B |
1092: Kidney Damage in Lupus Nephritis and Other Glomerular Diseases is Characterized by a Urinary Complement and Matrix Remodeling Signature | Poster Hall |
| Andrea Fava, MD |
10:30AM-12:30AM |
Poster Session B |
1220: Exploratory Urinary Biomarkers from an Open-Label Phase 1/2 Study of Rapcabtagene Autoleucel (YTB323) Suggest Reduced Intrarenal Inflammation in Severe Refractory Systemic Lupus Erythematosus | Poster Hall |
| Andrea Fava, MD |
10:30AM-12:30AM |
Poster Session B |
1092: Kidney Damage in Lupus Nephritis and Other Glomerular Diseases is Characterized by a Urinary Complement and Matrix Remodeling Signature | Poster Hall |
| Thomas Grader-Beck, MD | 10:30AM-12:30AM |
Poster Session B |
1392: Safety profile of ianalumab in Sjögren's disease: Observations from the pooled results of the phase 3 trials NEPTUNUS-1 and NEPTUNUS-2 up to 52 weeks. | Poster Hall |
| Thomas Grader-Beck, MD | 10:30AM-12:30AM |
Poster Session B | 1388: Oral Disease Burden and Risk of Systemic Infection and Sepsis in Adults with Sjögren's Disease: An Insurance Claims-Based Analysis | Poster Hall |
| Jin Liu (PhD Candidate) | 10:30AM-12:30AM |
Poster Session B |
1111: Precision Targeting of Autoreactive B Cells with Next-Generation CATCR-T Cells |
Poster Hall |
| Zixing Liu, MS | 10:30AM-12:30AM | Poster Session B |
1194: Pilot Study Assessing Home Spirometry for Lung Function Trajectory Monitoring in Systemic Sclerosis-Associated Interstitial Lung Disease |
Poster Hall |
| John Miller, MD | 10:30AM-12:30AM |
Poster Session B |
1670: Spondyloarthritis may be an Underrecognized Cause of Persistent Musculoskeletal Pain following Lyme Disease | Poster Hall |
| Julie Paik, MD, MHS | 10:30AM-12:30AM |
Poster Session B |
1585: Brepocitinib Demonstrates Consistent Benefit on Combined Measures of Clinical Response and Sustained Corticosteroid Tapering in Dermatomyositis Patients at One Year | Poster Hall |
| Michelle Petri, MD, MPH | 10:30AM-12:30AM |
Poster Session B |
1229: Kidney Function Preservation with Belimumab in Patients with Lupus Nephritis (LN) in Routine Care Settings: Preliminary 24-Month Interim Analysis of the OBSErve-LN Study | Poster Hall |
| Julia Shalen, MD, MEd | 10:30AM-12:30AM |
Poster Session B |
1483: Building the Next Generation: A Global Snapshot of Pediatric Rheumatology Training Programs |
Poster Hall |
| Susan Bartlett, MD, PhD | 11:00AM-11:30AM | Scientific Session | Building Smarter Rheumatology Registries: PROMIS as the Common Language |
W311GH |
| Julie Paik, MD, MHS | 11:00AM-11:30AM | Scientific Session | Early Idiopathic Inflammatory Myopathies: Subtle Presentations, Early Clues, and Extramuscular Disease |
W415A |
| Julie Paik, MD, MHS |
11:30AM-12:30PM | Meet the Professor | Myositis | W102A |
| Andrea Fava, MD | 4:20PM-4:40PM | Scientific Session | Bench to Bedside: Updates on Lupus Biomarkers |
|
| Lisa Christopher-Stine, MD, MPH | 5:30PM-7:30PM | Industry-Supported Event | Autoimmune Myositis Reframed: New Perspectives on Burden, Biology and Clinical Outcomes |
Hyatt Regency Orlando, Regency Ballroom Q |
| Faculty name | Time | Presentation Type | Title | Location |
|---|---|---|---|---|
| Laura Hummers, MD, ScM | 7:30AM-8:30AM | Meet the Professor | Systemic Sclerosis |
W103A |
| Felipe Andrade, MD, PhD | 8:00AM-8:15AM | Abstract Session | CD8 T Cell-Mediated Poly-Perforin Pore Formation Drives Neutrophil Hypercitrullination and T Cell Responses in Rheumatoid Arthritis |
W304A-H |
| Alan Baer, MD | 8:00AM-8:30AM | Scientific Session | Great Debate: In Favor of Doing Lip Biopsy | W415D |
| Andrea Fava, MD | 10:30AM-12:30PM |
Poster Session C |
2211: Improvement in Laboratory Markers of Disease Activity with Dapirolizumab Pegol Treatment in Patients with Systemic Lupus Erythematosus: Updated Analyses from a 48-Week Phase 3 Trial | Poster Hall |
| Thomas Grader-Beck, MD | 10:30AM-12:30PM |
Poster Session C | 2372: Patient Global Assessment Correlates With the EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI) and the Sjögren's Syndrome Symptom Diary (SSSD) in the Pooled Phase 3 NEPTUNUS Studies | Poster Hall |
| Thomas Grader-Beck, MD |
10:30AM-12:30PM | Poster Session C | 2372: Validation of ICD Diagnosis-Based and Large Language Model-Based Approaches to Identify Patients With Moderate to Severe Sjögren's Disease | Poster Hall |
| Michelle Petri, MD, MPH | 10:30AM-12:30PM | Poster Session C | 2255: Impact of Renin-Angiotensin-Aldosterone System Inhibitors on Venous Thromboembolism in Systemic Lupus Erythematosus | Poster Hall |
| Michelle Petri |
10:30AM-12:30PM | Poster Session C | 2257: Low 25(OH)-vitamin D is Associated with Venous Thromboembolism in SLE | Poster Hall |
| Michelle Petri, MD, MPH |
10:30AM-12:30PM |
Poster Session C |
2247: Early versus Late Cardiovascular Events in Systemic Lupus Erythematosus | Poster Hall |
| Michelle Petri, MD, MPH |
10:30AM-12:30PM |
Poster Session C |
2268: Pro-BNP in SLE is Associated with Lower GFR and Prednisone Use (Hydroxychloroquine May Be Protective) | Poster Hall |
| Marwin Groener, MD (Fellow) | 10:30AM-12:30PM |
Poster Session C |
2605: Younger Age Predicts Worse Long-term Outcomes Independent of Statin Exposure in Patients with anti-HMGCR Immune-mediated Necrotizing Myopathy | Poster Hall |
| Faith Obilo (RPC) | 10:30AM-12:30PM |
Poster Session C |
2277: The Effect of Body Mass Index (BMI) on eGFR Decline in Systemic Lupus Erythematosus versus Lupus Nephritis | Poster Hall |
| Clifton O. Bingham, III, MD | 2:15PM-2:30PM | Abstract Session | 2874: When Targets Don't Tell the Whole Story: Persistent Symptoms in "Controlled" Rheumatoid Arthritis | W311A-D |
| Julie Paik, MD, MHS | 3:00PM-3:15PM | Abstract Session | 2911: Paired Muscle and Blood Transcriptomics Reveal Distinct Tissue and Systemic Transcriptional Signatures Across Myositis Subtypes | W311A-D |
| Lisa Christopher-Stine, MD, MPH | 4:00PM-4:15PM | Abstract Session | 2921: From Hematologic Malignancies to Rheumatic Disease: Expanding the Role of Intravenous Immunoglobulin in Secondary Immunodeficiency | W415BC |
| Colin Gliech (Postdoc Fellow) |
4:00PM-4:15PM |
Abstract Session |
2891: Defining Pathogenic PR3-ANCA Through Functional and Structural Profiling | W110B |
| Julie Paik, MD, MHS |
4:00PM-5:00PM | Meet the Professor | Myositis | W102A |
| Lisa Christopher-Stine, MD, MPH |
5:30PM-7:30PM | Industry-Supported Event |
IIMagine What’s Next in Myositis Care: Integrating Targeted Strategies to Advance Patient Outcomes |
Hyatt Regency Orlando, Regency Ballroom P |
| Julie Paik, MD, MHS | 5:30PM-7:30PM |
Industry-Supported Event |
IIMagine What’s Next in Myositis Care: Integrating Targeted Strategies to Advance Patient Outcomes |
Hyatt Regency Orlando, Regency Ballroom P |
| Faculty name | Time | Presentation Type | Title | Location |
|---|---|---|---|---|
| Jemima Albayda, MD | 8:30AM-8:50AM | Scientific Session | Education and Wellness Inspirations: The Dining Rheum | W308 |
```
ACR 2025 Recap Videos
What We're Excited About at ACR 2025
Clinical Applications of Urinary Biomarkers in Lupus Nephritis
POTS: Postural Tachycardia Syndrome or Is It?
Urinary Tenascin C Predicts Kidney Function Loss in Lupus Nephritis
ACR 2024 Recap Videos
Stirring the POTS: Long COVID and Beyond
Urinary Biomarkers & Lupus Nephritis
The Importance of Patient Reported Outcomes in Clinical Care
